Citation: | LU Yuan, LIU Huan-le, MA Yun-tao, DAI Xiao-yu, WANG Zhi-heng, LIU Yan-xun. Association between total cholesterol and type 2 diabetes:a prospective cohort study[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(4): 380-383. doi: 10.16462/j.cnki.zhjbkz.2020.04.002 |
[1] |
钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志, 2000, 8(1): 5-6. DOI: 10.3321/j.issn:1006-6187.2000.01.001.
Qian RL. New diagnostic criteria and classification of diabetes mellitus[J]. Chin J Diabetes Mellitus, 2000, 8(1): 5-6. DOI: 10.3321/j.issn:1006-6187.2000.01.001.
|
[2] |
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(25): 2425. DOI: 10.1056/nejmoa0908292.
|
[3] |
Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J]. JAMA, 2017, 317(24): 2515. DOI: 10.1001/jama.2017.7596.
|
[4] |
Leahy JL. Pathogenesis of type 2 diabetes mellitus[J]. Arch Med Res, 2005, 36(3): 197-209. DOI: 10.1016/j.arcmed.2005.01.003.
|
[5] |
吴加华.胆固醇对胰岛beta-细胞的损害及GLP-1类似物的保护作用[D].杭州: 浙江大学, 2013.
Wu JH. Protective effect of GLP-1 analogue on the damage of cholesterol in pancreatic beta-cell[D]. Hangzhou: Zhejiang University, 2013.
|
[6] |
刘力生.中国高血压防治指南2010[J].中华高血压杂志, 2011, 19(8): 701-743. DOI: 10.16439/j.cnki.1673-7245.2011.08.009.
Liu LS. 2010 Chinese guidelines for the management of hypertension[J]. Chin J Hypertens, 2011, 19(8): 701-743. DOI: 10.16439/j.cnki.1673-7245.2011.08.009.
|
[7] |
潘长玉, 金文胜. 2型糖尿病流行病学[J].中华内分泌代谢杂志, 2005, 21(5): 1-5. DOI: 10.3760/j.issn:1000-6699.2005.05.039.
Pan CY, Jin WS. Epidemiology of type 2 diabetes mellitus[J]. Chin J Endocrinol Metab, 2005, 21(5): 1-5. DOI: 10.3760/j.issn:1000-6699.2005.05.039.
|
[8] |
Ho JE, Paultre F, Mosca L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women?data from the women's pooling project[J]. Stroke, 2003, 34(12): 2812-2816. DOI: 10.1161/01.STR.0000102901.41780.5C.
|
[9] |
Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study(CARDS): multicentre randomised placebo-controlled trial[J]. Lancet, 2004, 364(9435): 685-696. DOI: 10.1016/S0140-6736(04)16895-5.
|
[10] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志, 2014, 30(10): 893-942. DOI: 10.3760/cma.j.issn.1000-6699.2014.10.020.
Chinese diabetes society. Guidelines for the prevention and treatment of type 2 diabetes in China(2013)[J]. Chin J Endocfinol Metab, 2014, 30(10): 893-942. DOI: 10.3760/cma.j.issn.1000-6699.2014.10.020.
|
[11] |
陈思东, 俞守义, 许雅, 等. Ⅱ型糖尿病发病危险因素研究[J].中国公共卫生, 2002, 18(7): 814-815. DOI: 10.11847/zgggws2002-18-07-26.
Chen SD, Yu SY, Xu Y, et al. Study on risk factors for type 2 diabetes[J]. Chin J Public Health, 2002, 18(7): 814-815. DOI: 10.11847/zgggws2002-18-07-26.
|
[12] |
杨土保, 夏真芳.海口市城中村老年2型糖尿病患者多因素Logistic回归分析[J].中国老年学杂志, 2013, 33(24): 6245-6247. DOI: 10.3969/j.issn.1005-9202.2013.24.079.
Yang SB, Xia ZF. Multivariate logistic regression analysis of senile type 2 diabetes mellitus in urban village of Haikou city[J]. Chin J Gerontol, 2013, 33(24): 6245-6247. DOI: 10.3969/j.issn.1005-9202.2013.24.079.
|
[13] |
张阳丹, 唐晓君, 李革, 等.肥胖及血脂异常与2型糖尿病关系[J].中国公共卫生, 2010, 26(9): 1112-1113. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgggws201009014
Zhang YD, Tang XJ, Li G, et al. The relationship between obesity, dyslipidemia and type 2 diabetes[J]. Chin J Public Health, 2010, 26(9): 1112-1113. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgggws201009014
|
[14] |
周静雯.血脂与糖代谢异常关系的队列研究[D].苏州: 苏州大学, 2015.
Zhou JW. A cohort study on the relationship between serum lipids and glucose metabolic disorder[D]. Suzhou: Suzhou University, 2015.
|
[15] |
顾刘金.应用广义估计方程分析纵向数据[J].预防医学, 2018, 30(1): 106-107. DOI: 10.3969/j.issn.1007-0931.2018.01.032.
Gu LJ. Analysis of longitudinal data by generalized estimation equation[J]. Prevent Med, 2018, 30(1): 106-107. DOI: 10.3969/j.issn.1007-0931.2018.01.032.
|
[16] |
张茜, 朱振昕, 孟文佳, 等.纵向监测健康体检数据的统计分析策略[J].山东大学学报(医学版), 2012, 50(2): 149. DOI: 10.6040/j.issn.1671-7554.2012.02.035.
Zhang Q, Zhu ZX, Meng WJ, et al. Longitudinal monitoring large-scale health check-up data analysis strategy[J]. J Shandong Univ Health Sci, 2012, 50(2): 149. DOI: 10.6040/j.issn.1671-7554.2012.02.035.
|
[17] |
张秋梅, 靳建鸣, 管乐, 等. 2型糖尿病患者高危因素分析[J].中国慢性病预防与控制, 2003, 11(2): 61-62. DOI: 10.3969/j.issn.1004-6194.2003.02.006.
Zhang QM, Jin JM, Guan L, et al. Clinical analysis of risk factors for type 2 diabetes patients[J]. Chin J Prevent Control Chronic Dis, 2003, 11(2): 61-62. DOI: 10.3969/j.issn.1004-6194.2003.02.006.
|
[18] |
Cui J, Sun J, Wang W, et al. The association of triglycerides and total cholesterol concentrations with newly diagnosed diabetes in adults in China[J]. Oncotarget, 2017, 8(61). DOI: 10.18632/oncotarget.21969.
|
[19] |
高静, 段畅, 李丽娟. 2型糖尿病发病机制的研究进展[J].医学综述, 2015(21): 3935-3938. DOI: 10.3969/j.issn.1006-2084.2015.21.033.
Gao J, Duan C, Li LJ. The pathogenesis mechanisms of type 2 diabetes mellitus[J]. Med Recapitulate, 2015(21): 3935-3938. DOI: 10.3969/j.issn.1006-2084.2015.21.033.
|
[20] |
Fryirs M, Barter PJ, Rye KA. Cholesterol metabolism and pancreatic beta-cell function[J]. Curr Opin Lipidol, 2009, 20(3): 159-164. DOI: 10.1097/mol.0b013e32832ac180.
|
[21] |
吴加华, 周嘉强.胆固醇代谢紊乱与胰岛β细胞功能障碍[J].中华糖尿病杂志, 2017, 9(9): 588-590. DOI: 10.3760/cma.j.issn.1674-5809.2017.09.012.
Wu JH, Zhou JQ. Cholesterol metabolic disorder and islet beta-cell dysfunction[J]. Chin J Diabetes Mellitus, 2017, 9(9): 588-590. DOI: 10.3760/cma.j.issn.1674-5809.2017.09.012.
|
[22] |
王坤林, 周红文.胆固醇代谢与胰岛β细胞功能[J].国际内分泌代谢杂志, 2011, 31(6): 397-399. DOI: 10.3760/cma.j.issn.1673-4157.2011.06.011.
Wang KL, Zhou HW. Cholesterol metabolism and islet beta cell function[J]. Int J Endocrinol Metab, 2011, 31(6): 397-399. DOI: 10.3760/cma.j.issn.1673-4157.2011.06.011.
|
[23] |
Lu X, Liu J, Hou F, et al. Cholesterol induces pancreatic β cell apoptosis through oxidative stress pathway[J]. Cell Stress Chaperones, 2011, 16(5): 539-548. DOI: 10.1007/s12192-011-0265-7.
|